课题基金 / 基金详情

Combining stem cell science and tissue engineering to study the development and repair of human skeletal tissue

Combining stem cell science and tissue engineering to study the development and repair of human skeletal tissue
结合干细胞科学和组织工程学研究人体骨骼组织的发育和修复
批准号:
BB/G010579/1
负责人:
Richard Oreffo
金额:
$203.97万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2009
资助国家:
英国
项目状态:
已结题
起止时间:
2009 至 --

项目摘要

项目成果

Richard Oreffo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
With an ever increasing ageing population, strategies that allow the simple repair and enhancement of bone tissue, lost due to diseases such as osteoporosis and osteoarthritis or with ageing or after an accident, are urgently needed. Whilst there are a number of surgical techniques that can be used to repair bone and to aid fracture healing, there is a great need for the development of alternative bone and cartilage repair and regeneration strategies. To try and solve the lack of bone a patient may have at one site, the surgeon can try and harvest and use existing bone from another site (known as autogenous bone) in the patient although, naturally, the amounts available to use are limited. Other options include the use of donor bone from a different individual (known as allogeneic bone). However donor bone carries risks of rejection and infection. Tissue engineering aims to make tissues and organs - including bone tissue - using stem and precursor cells, scaffolds upon which the cells can grow and be guided, and necessary mechanical cues to create bone tissue in the laboratory for transplantation to replace damaged or diseased tissues. Within all our bone marrow are stem cells (called skeletal or mesenchymal stem cells), which can be isolated using selective markers and which can be grown up to give lots of cells, while retaining their ability to form a variety of tissues like bone and fat. Similarly we have expertise in the ability to create structures (scaffolds) for the cells to grow on and these scaffolds can be tailored to release select growth factors and proteins needed to guide and tell the stem cells to make bone and cartilage. In addition, we know that mechanical cues are very important in stimulating new bone growth (for example we know excessive bed rest or weightlessness leads to loss of bone). Thus the application of stem cells, select scaffolds and the use of signalling cues to generate new bone tissue is currently one of the most exciting and promising areas for disease treatment and bone repair. We propose as well as combining these key ingredients, that, critically, a new way of thinking as to how scientists currently try to create skeletal tissue is urgently needed if we are to meet the challenges of new skeletal formation for an increasing ageing population. We propose that it is vital to understand bone development and formation and that if we can harness the information of how bone develops and if we can understand bone biology, this will set the foundation and inform us how to repair and make new skeletal tissue. Thus, we propose an ambitious programme of research to significantly advance the state-of-the-art in developmental biology, stem cells, materials chemistry, mechanical signalling and loading and translational medicine to generate new models of skeletal development that can be used to inform skeletal repair strategies for clinical use in bone repair and regeneration. To achieve our goal we will use a multidisciplinary strategy that brings together stem cell biologists, developmental biologists, materials scientists, mechanobiologists and clinicians with an ability to draw lessons from skeletal developmental biology to inform our tissue engineering strategy for skeletal formation and repair.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.actbio.2013.11.008
发表时间: 2014-02
期刊: ACTA BIOMATERIALIA
影响因子: 9.7
作者: [Cassidy, John W., Roberts, Jemma N., Smith, Carol-Anne, Robertson, Mary, White, Kate, Biggs, Manus J., Oreffo, Richard O. C., Dalby, Matthew J.]
通讯作者: Dalby, Matthew J.
DOI: 10.1016/j.bonr.2021.101143
发表时间: 2021-12
期刊: Bone reports
影响因子: 2.5
作者: [Alghfeli L, Parambath D, Manzoor S, Roach HI, Oreffo ROC, El-Serafi AT]
通讯作者: El-Serafi AT
DOI: 10.1016/j.surge.2013.02.008
发表时间: 2013-12
期刊: SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND
影响因子: 2.5
作者: [Aarvold, A., Smith, J. O., Tayton, E. R., Jones, A. M. H., Dawson, J. I., Lanham, S., Briscoe, A., Dunlop, D. G., Oreffo, R. O. C.]
通讯作者: Oreffo, R. O. C.
DOI: 10.1007/s40610-015-0022-2
发表时间: 2015
期刊: Current molecular biology reports
影响因子: --
作者: [Black CR, Goriainov V, Gibbs D, Kanczler J, Tare RS, Oreffo RO]
通讯作者: Oreffo RO
6
    Correlative In Vivo Fluorescence and Micro-Computed Tomographic Imaging of Tissue Structure and Function
    • 批准号:
      BB/S019480/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $71.75万
    • 财政年份:
      2019
    • 负责人:
      Richard Oreffo
    • 依托单位:
    Identifying the skeletal stem cell for regeneration: harnessing smart nanoparticles and single cell DropSeq molecular profiling platforms
    • 批准号:
      BB/P017711/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $86.08万
    • 财政年份:
      2017
    • 负责人:
      Richard Oreffo
    • 依托单位:
    Harnessing Clay Gels for Cell, Growth Factor and Protein delivery for Regenerative Medicine
    • 批准号:
      BB/P017304/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $2.49万
    • 财政年份:
      2016
    • 负责人:
      Richard Oreffo
    • 依托单位:
    Smart materials for targeted stem cell fate and function in skeletal repair
    • 批准号:
      BB/L00609X/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $55.19万
    • 财政年份:
      2014
    • 负责人:
      Richard Oreffo
    • 依托单位:
    国内基金
    海外基金
    LIPUS促进微环境巨噬细胞释放CCL2诱导尿道周围平滑肌祖细胞定植与分化的机制研究
    • 批准号:
      82370780
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      夏术阶
    • 依托单位:
    骨髓抑制再生单个核细胞移植通过调节线粒体功能在脑缺血再灌注损伤中的神经保护机制研究
    • 批准号:
      82371301
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      李轶
    • 依托单位:
    血管内皮细胞源性的外泌体通过Notch信号通路增强肿瘤细胞可塑性的机制研究
    • 批准号:
      32100627
    • 项目类别:
      青年科学基金项目(C类)
    • 资助金额:
      30.0万元
    • 批准年份:
      2021
    • 负责人:
      张宇
    • 依托单位:
    哺乳动物新生期心肌细胞增殖及其调控机制研究